Novel Cell Sorting and Separation Market 2020-2025: Assessment and Growth Opportunities by Leading Players - QIAGEN, NanoCellect Biomedical, Innovative Biochips, RareCyte, Cytonome

Global Novel Cell Sorting and Separation Market Synopsis:

The exclusive research report on the Global Novel Cell Sorting and Separation Market 2020-2025 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market. Global Novel Cell Sorting and Separation Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe.

As per the Novel Cell Sorting and Separation Market research study, advances in the fields of cell biology and regenerative medicine have led to the development of various cell-based therapies, which, developers claim, possess the potential to treat a variety of clinical conditions. In 2018, it was reported that there were more than 1,000 clinical trials of such therapies, being conducted across the globe by over 900 industry players. Given the recent breakthroughs in clinical testing and the discovery of a variety of diagnostic biomarkers, the isolation of one or multiple cell types from a heterogenous population has not only become simpler but also an integral part of modern clinical R&D. The applications of cell separation technologies are vast, starting from basic research to biological therapy development and manufacturing.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/273428 .

Significant points in table of contents: Market Definition, Market Overview, Business Introduction, Segmentation (Region Level), Segmentation (Type Level), Segmentation (Industry Level), Segmentation (Channel Level), Market Forecast Year, Segmentation Type, Segmentation Industry, Market Cost Analysis, and Conclusion. The Novel Cell Sorting and Separation Market is segmented based on Product, source, application and Regions. On the basis of product, the market is sub-segmented.

In terms of the geographic analysis, North America and Europe holds major share in Global Novel Cell Sorting and Separation Market. Moreover, Asia-Pacific is expected to record higher growth rate in Novel Cell Sorting and Separation market during the forecast year.

Top Major Key Players in the Global Novel Cell Sorting and Separation Market:

1 NanoCellect Biomedical

2 Innovative Biochips

3 Cesca Therapeutics

4 Fluidigm

5 LumaCyte

6 Union Biometrica

7 LevitasBio

8 RareCyte

9 Cytonome

10 Namocell

11 STEMCELL Technologies

12 Akadeum Life Sciences

13 QIAGEN

14 ScreenCell and More………………..

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “Global Novel Cell Sorting and Separation Market Report 2020” @ https://www.businessindustryreports.com/buy-now/273428/single .

Product Type Segmentation

1 Cancer Cell

2 Immune Cells

3 Microbial Cell

4 Red Blood Cell/Platelet

5 Stem Cell

Industry Segmentation

1 Cell Research

2 Biomedical Diagnosis

Global Business News:

QIAGEN (July 16, 2020) - Thermo Fisher Scientific and QIAGEN N.V. Agree on Amended Terms to Acquisition Agreement - Thermo Fisher Scientific Inc., the world leader in serving science, and QIAGEN N.V., a leading global provider of Sample to Insight molecular diagnostics and sample preparation technologies, today announced that they have entered into an amendment to their acquisition agreement under which Thermo Fisher has commenced a tender offer to acquire all of the ordinary shares of QIAGEN.

The amendment provides for an increase from the original offer price of €39.00 to a new price of €43.00 per QIAGEN share in cash, which represents a premium of approximately 35% to the closing price of QIAGEN’s ordinary shares on the Frankfurt Prime Standard on March 2, 2020, the last trading day prior to the announcement of the acquisition agreement and Thermo Fisher’s intention to commence the offer. The amendment also provides for a reduction of the minimum acceptance threshold from 75% to 66.67% of QIAGEN’s issued and outstanding ordinary share capital at the end of the acceptance period on August 10, 2020, as well as a USD 95 million expense reimbursement to Thermo Fisher if the minimum acceptance threshold is not met.

The members of QIAGEN’s Supervisory Board and Managing Board have reaffirmed their unanimous support for the offer and their unanimous recommendation that all QIAGEN shareholders accept and tender all of their QIAGEN shares in the offer prior to the end of the acceptance period, which has now been extended to August 10, 2020. Each of the members of the Supervisory Board and Managing Board has tendered or will tender all of their QIAGEN shares in the offer.

Marc N. Casper, chairman, president and chief executive officer of Thermo Fisher Scientific, said, “Industry dynamics have changed considerably in the past few months, creating tailwinds and headwinds for our businesses. Both of our companies are playing important roles in helping customers to battle the COVID-19 pandemic. After careful consideration, we’ve decided to increase our offer for QIAGEN to reflect the fair value of the business given the current environment. We remain confident that this transaction will create shareholder value and, importantly, provide meaningful benefits to our customers and society by combining our capabilities to combat infectious diseases and other healthcare issues. We continue to look forward to completing the transaction in the first half of 2021.”

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/273428 .

Major Points in Table of Contents:

Global Novel Cell Sorting and Separation Market Report 2020

1 Novel Cell Sorting and Separation Product Definition

2 Global Novel Cell Sorting and Separation Market Manufacturer Share and Market Overview

2.1 Global Manufacturer Novel Cell Sorting and Separation Shipments

2.2 Global Manufacturer Novel Cell Sorting and Separation Business Revenue

2.3 Global Novel Cell Sorting and Separation Market Overview

2.4 COVID-19 Impact on Novel Cell Sorting and Separation Industry

3 Manufacturer Novel Cell Sorting and Separation Business Introduction

3.1 NanoCellect Biomedical Novel Cell Sorting and Separation Business Introduction

3.2 Innovative Biochips Novel Cell Sorting and Separation Business Introduction

3.3 Cesca Therapeutics Novel Cell Sorting and Separation Business Introduction

3.4 Fluidigm Novel Cell Sorting and Separation Business Introduction

3.5 LumaCyte Novel Cell Sorting and Separation Business Introduction

3.6 Union Biometrica Novel Cell Sorting and Separation Business Introduction

About us

BusinessindustryReports.com is a digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic, and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.